163 related articles for article (PubMed ID: 17824811)
1. Chronic low-dose L-NAME treatment increases nitric oxide production and vasorelaxation in normotensive rats.
Bernátová I; Kopincová J; Púzserová A; Janega P; Babál P
Physiol Res; 2007; 56 Suppl 2():S17-S24. PubMed ID: 17824811
[TBL] [Abstract][Full Text] [Related]
2. Effect of blood pressure on L-NAME-sensitive component of vasorelaxation in adult rats.
Púzserová A; Csizmadiová Z; Bernátová I
Physiol Res; 2007; 56 Suppl 2():S77-S84. PubMed ID: 17824803
[TBL] [Abstract][Full Text] [Related]
3. Vascular effects of long-term propranolol administration after chronic nitric oxide blockade.
Priviero FB; Teixeira CE; Claudino MA; De Nucci G; Zanesco A; Antunes E
Eur J Pharmacol; 2007 Oct; 571(2-3):189-96. PubMed ID: 17610863
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive systems in L-NAME hypertension: the role of inducible nitric oxide synthase.
Pechánová O; Dobesová Z; Cejka J; Kunes J; Zicha J
J Hypertens; 2004 Jan; 22(1):167-73. PubMed ID: 15106808
[TBL] [Abstract][Full Text] [Related]
5. Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor.
Paulis L; Zicha J; Kunes J; Hojna S; Behuliak M; Celec P; Kojsova S; Pechanova O; Simko F
Hypertens Res; 2008 Apr; 31(4):793-803. PubMed ID: 18633192
[TBL] [Abstract][Full Text] [Related]
6. Acute intravenous injection and short-term oral administration of N(G) -nitro-L-arginine methyl ester to the rat provoke increased pressor responses to agonists and hypertension, but not inhibition of acetylcholine-induced hypotensive responses.
López RM; Pérez T; Castillo C; Castillo MC; Castillo EF
Fundam Clin Pharmacol; 2011 Jun; 25(3):333-42. PubMed ID: 20608990
[TBL] [Abstract][Full Text] [Related]
7. Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation?
Kopincova J; Puzserova A; Bernatova I
Neuro Endocrinol Lett; 2008 Oct; 29(5):784-9. PubMed ID: 18987608
[TBL] [Abstract][Full Text] [Related]
8. Hypertension and impairment of endothelium-dependent relaxation of arteries from spontaneously hypertensive and L-NAME-treated Wistar rats.
Sekiguchi F; Miyake Y; Hirakawa A; Nakahira T; Yamaoka M; Shimamura K; Yamamoto K; Sunano S
J Smooth Muscle Res; 2001 Apr; 37(2):67-79. PubMed ID: 11592285
[TBL] [Abstract][Full Text] [Related]
9. Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
Sládková M; Kojsová S; Jendeková L; Pechánová O
Physiol Res; 2007; 56 Suppl 2():S85-S91. PubMed ID: 17824802
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of chronic and acute administration of NG-nitro-L-arginine methyl ester to the rat on inhibition of nitric oxide-mediated responses.
Bryant CE; Allcock GH; Warner TD
Br J Pharmacol; 1995 Apr; 114(8):1673-9. PubMed ID: 7541283
[TBL] [Abstract][Full Text] [Related]
11. Vascular function and nitric oxide production in chronic social-stress-exposed rats with various family history of hypertension.
Bernatova I; Csizmadiova Z; Kopincova J; Puzserova A
J Physiol Pharmacol; 2007 Sep; 58(3):487-501. PubMed ID: 17928645
[TBL] [Abstract][Full Text] [Related]
12. Failure of L-nitroarginine to inhibit the activity of aortic inducible nitric oxide synthase.
Darblade B; Batkai S; Caussé E; Gourdy P; Fouque MJ; Rami J; Arnal JF
J Vasc Res; 2001; 38(3):266-75. PubMed ID: 11399899
[TBL] [Abstract][Full Text] [Related]
13. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs.
Tayama S; Okumura K; Matsunaga T; Tsunoda R; Tabuchi T; Iwasa A; Yasue H
Jpn Circ J; 1998 May; 62(5):371-8. PubMed ID: 9626906
[TBL] [Abstract][Full Text] [Related]
14. Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems.
Namiranian K; Samini M; Mehr SE; Gaskari SA; Rastegar H; Homayoun H; Dehpour AR
Eur J Pharmacol; 2001 Jul; 423(2-3):185-93. PubMed ID: 11448484
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats.
Orange SJ; Ledingham JM; Laverty R
Clin Exp Pharmacol Physiol; 2000 Jul; 27(7):488-93. PubMed ID: 10874504
[TBL] [Abstract][Full Text] [Related]
17. The role of hydrogen sulfide generation in the pathogenesis of hypertension in rats induced by inhibition of nitric oxide synthase.
Zhong G; Chen F; Cheng Y; Tang C; Du J
J Hypertens; 2003 Oct; 21(10):1879-85. PubMed ID: 14508194
[TBL] [Abstract][Full Text] [Related]
18. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
19. Vascular responses after long-term inhibition of nitric oxide synthesis in newborn dogs.
Török J; Gerová M
Physiol Res; 1996; 45(4):323-8. PubMed ID: 9085357
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro evidence of altered nitric oxide metabolism in the spontaneously diabetic, insulin-dependent BB/Edinburgh rat.
Lindsay RM; Peet RS; Wilkie GS; Rossiter SP; Smith W; Baird JD; Williams BC
Br J Pharmacol; 1997 Jan; 120(1):1-6. PubMed ID: 9117082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
